Merck/Schering's Vytorin Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Zetia/Zocor fixed-dose combination will be marketed as a first-line therapy for cholesterol.
You may also be interested in...
Merck To Support Zocor Into 2006 Based On Strong Formulary Position
Position of Zocor, Vytorin on Express Scripts' preferred formulary is a win-win for Merck, CEO Clark states during Q3 call.
Merck To Support Zocor Into 2006 Based On Strong Formulary Position
Position of Zocor, Vytorin on Express Scripts' preferred formulary is a win-win for Merck, CEO Clark states during Q3 call.
AstraZeneca Launches New Crestor DTC Ad Campaign
The firm is managing the right level of investment for Crestor, CFO Symonds tells analysts. The statin has a 7.6% share of new prescriptions for the week ending Oct. 8.